Seeing Is Believing
BPMC is currently covered by 20 analysts with an average price target of $109.44. This is a potential upside of $17.18 (18.62%) from yesterday's end of day stock price of $92.26.
Blueprint Medicines Corp's activity chart (see below) currently has 171 price targets and 193 ratings on display. The stock rating distribution of BPMC is 68.67% BUY, 22.89% HOLD and 8.43% SELL.
Analysts average stock forecasts to be materialized ratio is 78.05% with an average time for these price targets to be met of 233.39 days.
Highest price target for BPMC is $115, Lowest price target is $43, average price target is $109.44.
Most recent stock forecast was given by AMI FADIA from NEEDHAM on 26-Feb-2024. First documented stock forecast 26-May-2015.
Currently out of the existing stock ratings of BPMC, 57 are a BUY (68.67%), 19 are a HOLD (22.89%), 7 are a SELL (8.43%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
97
$4.74 (5.14%)
74
1 months 30 days ago
11/11 (100%)
$1.95 (2.05%)
89
Sell
65
$-27.26 (-29.55%)
46
2 months 9 days ago
10/11 (90.91%)
$-25.26 (-27.99%)
249
Buy
114
$21.74 (23.56%)
114
2 months 9 days ago
2/11 (18.18%)
$23.74 (26.30%)
273
Hold
70
$-22.26 (-24.13%)
58
2 months 12 days ago
8/9 (88.89%)
$-3.17 (-4.33%)
66
Buy
97
$4.74 (5.14%)
90
3 months 16 days ago
7/12 (58.33%)
$14.02 (16.90%)
229
What is BPMC (Blueprint Medicines Corp) average time for price targets to be met?
Which analyst has the current highest performing score on BPMC (Blueprint Medicines Corp) with a proven track record?
Which analyst has the most public recommendations on BPMC (Blueprint Medicines Corp)?
Which analyst is the currently most bullish on BPMC (Blueprint Medicines Corp)?
Which analyst is the currently most reserved on BPMC (Blueprint Medicines Corp)?